Extended Lymph Node Dissection for Gastric Cancerd: Is It of Value?

Behrns, Kevin E.; Dalton, Rory R.; Heerden, Jon A. van; Sarr, Michael C.

doi:10.1016/s0039-6109(16)45688-4

Cited by 34 publications

(13 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although 60-80% of the tumours are resectable, only 30% of them are at favourable stages I or II (1,8,12). In the series of JAKL (2), the 5-year survival following resection was 15% and similar results were given by others (7,13,14). In our series, 10 (25.6%) out of 39 resectable patients had stage I and II disease.…”

Section: Discussionsupporting

confidence: 90%

Analysis of Clinicopathological Prognostic Parameters in Adenocarcinoma of the Gastric Cardia

Ertürk

Çiçek

Ersan

et al. 2003

Acta Chirurgica Belgica

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

Analysis of Clinicopathological Prognostic Parameters in Adenocarcinoma of the Gastric Cardia

Ertürk

Çiçek

Ersan

et al. 2003

Acta Chirurgica Belgica

View full text Add to dashboard Cite

show abstract

“…These studies report that D2 dissection improves survival even in Western countries [8,9,10,11]. Thus, while a universal trend is lacking [12], there appears to be more support for performance of D2 lymphadenectomy in centers with special interest in gastric cancer surgery. The experience accumulated worldwide further convinced us to attempt and establish D2 lymphadenectomy as the procedure of choice in our institution.…”

Section: Discussionmentioning

confidence: 99%

D2 Lymphadenectomy for Gastric Cancer in Tata Memorial Hospital: Indian Data Can Now Be Incorporated in Future International Trials

Shrikhande¹,

Shukla²,

Qureshi³

et al. 2006

Dig Surg

View full text Add to dashboard Cite

Background: While mortality rates after radical gastrectomy have decreased, there is considerable morbidity after D2 lymphadenectomy. In this study, we assessed the perioperative results of D2 gastrectomy for gastric cancer. Materials: Data of 159 patients who underwent D2 gastrectomy for gastric adenocarcinoma at Tata Memorial Hospital was analyzed for interim analysis. The extent of resection, blood loss, transfusions, duration of hospitalization, number of lymph nodes dissected, complications, morbidity and mortality were analyzed. Results: 130 and 29 patients underwent distal and total gastrectomy, respectively (2002–2005) by single specialized surgical unit. Median age was 55 years (range 21–78) and blood loss was 450 ml (range 100–2,200 ml). The median duration of hospitalization was 13 days (range 7–52 days). The median number of dissected lymph nodes was 15 (range 2–46). Minor and major morbidity rate was 4.4 and 4.4% respectively. Mortality rate was 1.25%. Conclusion: Morbidity and mortality following D2 lymphadenectomy is low in this first prospective study from India. With Japan and Western countries having polarized views on D2 lymphadenectomy, future international multicenter trials could also incorporate data such as ours from areas of high incidence of gastric cancer since perioperative outcomes would no longer cloud their results and might provide a better global perspective on D2 lymphadenectomy.

show abstract

“…8,15 Metastatic involvement of the liver, adrenal glands, kidneys, ovaries, or peritoneal cavity was evaluated, 16,17 as well as the presence of ascites.…”

Section: Methodsmentioning

confidence: 99%

Dynamic CT in the Preoperative Evaluation of Patients With Gastric Cancer: Correlation With Surgical Findings and Pathology

Paramo

Gómez

1999

Ann Surg Oncol

View full text Add to dashboard Cite

Dynamic CT is a useful modality that can indicate inoperable disease, obviating the need for laparotomy in patients with gastric adenocarcinoma. CT can modify the surgical approach by suggesting unresectable or advanced disease. The low percentage of patients that are overstaged by CT, combined with its similar staging accuracy when compared with laparotomy, support its preoperative use in these patients.

show abstract

Extended Lymph Node Dissection for Gastric Cancerd: Is It of Value?

Cited by 34 publications

References 28 publications

Analysis of Clinicopathological Prognostic Parameters in Adenocarcinoma of the Gastric Cardia

Analysis of Clinicopathological Prognostic Parameters in Adenocarcinoma of the Gastric Cardia

D2 Lymphadenectomy for Gastric Cancer in Tata Memorial Hospital: Indian Data Can Now Be Incorporated in Future International Trials

Dynamic CT in the Preoperative Evaluation of Patients With Gastric Cancer: Correlation With Surgical Findings and Pathology

Contact Info

Product

Resources

About